Quarterly subscription
Quarterly tracking of the high-cost drug market in Argentina and of its implications for the subscriber's portfolio.
Each edition consists of a report and an Excel file with every data series: payments from SURGE, the national reimbursement mechanism for high-cost treatments, by payer; centralized purchasing and tenders with unit prices; the gap between the price actually paid and the list price, and its relation to the reimbursement value, for up to five molecules defined with the subscriber (additional molecules are quoted separately); and the quarter's regulatory changes, each with its implication. The report closes with a section of implications for the subscriber's portfolio and is presented in a 60-minute session with the subscriber's team.
El precio lo fija el que compra: high-cost drugs and access in Argentina (in Spanish).
A notice is sent by email on the day of publication.
The monitor does not include sales data by payer, interviews with payers (the purpose of the KHIN Panel) or pricing recommendations for a specific product (the purpose of the Decision Sprint).
A Decision Sprint on a portfolio molecule the monitor identifies as at risk.